Venerito V, Vescovo S, Lopalco G, Proft F
Arch Rheumatol. 2023; 38(4):491-511.
PMID: 38125058
PMC: 10728740.
DOI: 10.46497/ArchRheumatol.2023.10580.
Exarchou S, Lindstrom U, Askling J, Eriksson J, Forsblad-dElia H, Neovius M
Arthritis Res Ther. 2015; 17:118.
PMID: 25956915
PMC: 4424886.
DOI: 10.1186/s13075-015-0627-0.
Rashid T, Wilson C, Ebringer A
Rheumatol Int. 2014; 35(6):945-51.
PMID: 25385438
DOI: 10.1007/s00296-014-3164-2.
van Tubergen A
Nat Rev Rheumatol. 2014; 11(2):110-8.
PMID: 25385414
DOI: 10.1038/nrrheum.2014.181.
Exarchou S, Redlund-Johnell I, Karlsson M, Mellstrom D, Ohlsson C, Turesson C
BMC Musculoskelet Disord. 2013; 14:352.
PMID: 24330533
PMC: 3878735.
DOI: 10.1186/1471-2474-14-352.
Epidemiology of spondyloarthritis: a review.
Bakland G, Nossent H
Curr Rheumatol Rep. 2013; 15(9):351.
PMID: 23888360
DOI: 10.1007/s11926-013-0351-1.
The epidemiology of back pain, axial spondyloarthritis and HLA-B27 in the United States.
Reveille J, Weisman M
Am J Med Sci. 2013; 345(6):431-6.
PMID: 23841117
PMC: 4122314.
DOI: 10.1097/maj.0b013e318294457f.
Epidemiology of spondyloarthritis.
Stolwijk C, Boonen A, van Tubergen A, Reveille J
Rheum Dis Clin North Am. 2012; 38(3):441-76.
PMID: 23083748
PMC: 4470267.
DOI: 10.1016/j.rdc.2012.09.003.
Human leukocyte antigen-B*2705 is the predominant subtype in the Korean population with ankylosing spondylitis, unlike in other Asians.
Lee S, Choi I, Lee Y, Park E, Kim Y, Kim K
Rheumatol Int. 2008; 29(1):43-6.
PMID: 18493767
DOI: 10.1007/s00296-008-0602-z.
Acetabular dysplasia as an aetiological factor in development of hip osteoarthritis.
Johnsen K, Goll R, Reikeras O
Int Orthop. 2008; 33(3):653-7.
PMID: 18478228
PMC: 2903113.
DOI: 10.1007/s00264-008-0554-7.
Performance of referral recommendations in patients with chronic back pain and suspected axial spondyloarthritis.
Brandt H, Spiller I, Song I, Vahldiek J, Rudwaleit M, Sieper J
Ann Rheum Dis. 2007; 66(11):1479-84.
PMID: 17456526
PMC: 2111623.
DOI: 10.1136/ard.2006.068734.
Association of the programmed cell death 1 (PDCD1) gene polymorphism with ankylosing spondylitis in the Korean population.
Lee S, Lee Y, Woo D, Song R, Park E, Ryu M
Arthritis Res Ther. 2006; 8(6):R163.
PMID: 17064404
PMC: 1794506.
DOI: 10.1186/ar2071.
How early should ankylosing spondylitis be treated with tumour necrosis factor blockers?.
Sieper J, Rudwaleit M
Ann Rheum Dis. 2005; 64 Suppl 4:iv61-4.
PMID: 16239391
PMC: 1766918.
DOI: 10.1136/ard.2005.042432.
Ethnic variation of Fc gamma receptor polymorphism in Sami and Norwegian populations.
Torkildsen O, Utsi E, Mellgren S, Harbo H, Vedeler C, Myhr K
Immunology. 2005; 115(3):416-21.
PMID: 15946259
PMC: 1782156.
DOI: 10.1111/j.1365-2567.2005.02158.x.
Seronegative spondyloarthropathies in Greece: a population-based study of prevalence, clinical pattern, and management. The ESORDIG study.
Trontzas P, Andrianakos A, Miyakis S, Pantelidou K, Vafiadou E, Garantziotou V
Clin Rheumatol. 2005; 24(6):583-9.
PMID: 15864686
DOI: 10.1007/s10067-005-1106-9.
Epidemiology of HLA-B27 and Arthritis.
Khan M
Clin Rheumatol. 1996; 15 Suppl 1:10-2.
PMID: 8835494
DOI: 10.1007/BF03342637.